We previously observed that Mcm5 is overexpressed in prostate cancer and that raised Mcm5 protein levels are an independent predictor of survival on multivariate analysis in patients treated with radical surgery (Meng et al, 2001) or androgen deprivation therapy and radiotherapy (Dudderidge et al, 2007). This evidence concerns the gene MCM5 and Familial prostate cancer.